Direct Oral Anticoagulants: Determining Proper Use and Dose

Description

Despite a growing body of clinical data on direct oral anticoagulants (DOACs), use and dosage doubts persist. What are the safety concerns regarding these medications? How do you determine the right dose for individual patients? Can a DOAC overdose be reversed? Learn about recent advances—and challenges—in anticoagulation therapy during this interactive session, and get all the answers you need to make these clinical decisions with confidence.

This session will be audio-recorded and offered as part of the Home-Study on Demand, included with Premium Registration or available for purchase on-site at the Education Booth.

Pharmacist Learning Objectives

At the completion of this application-based activity, participants will be able to:

  1. Develop an evidence-based patient care plan for a patient requiring treatment with a direct oral anticoagulant (DOAC).
  2. Identify patients who are at high risk for adverse events associated with DOAC therapy and strategies for managing these patients.
  3. Discuss strategies that optimize adherence and outcomes for patients receiving DOAC therapy.
 
 

Supporter

This activity is supported by independent educational grants from Boehringer Ingelheim Pharmaceuticals, Inc., and the Bristol-Myers Squibb and Pfizer Alliance.

 
Speakers:
Brent
Brent Reed, BS, PHARMD
 
Toby
Toby Trujillo,
Associate Professor
University of Colorado
 
Learning Level: Level 2
Pathway: Home-Study on Demand
Track: Clinical Patient Care and Services
Session Time Slot(s): 
Date: 
Monday, March 19
Time: 
10:00 AM - 11:30 AM
Room: 
Music City Center - Room 104C-D
ACPE Pharmacist: 0202-0000-18-048-L01-P
CEUs Pharmacist: 0.15
Activity Type:
Application-based